CD34-selected hematopoietic stem cell transplants conditioned with myeloablative regimens and anti-thymocyte globulin for advanced myelodysplastic syndrome: limited graft-versus-host disease without increased relapse

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative therapy for patients with myelodysplastic syndrome (MDS). Donor T cells are critical for graft-versus-tumor effect (GVT) but carry the risk of graft-versus-host disease (GVHD). CD34 selection with immunomagnetic bead...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Tamari, Roni, Chung, Steven, Papadopoulos, Esperanza B., Jakubowski, Ann A., Hilden, Patrick, Devlin, Sean M., Goldberg, Jenna D., Perales, Miguel-Angel, Ponce, Doris M., Sauter, Craig S., Maloy, Molly A., Herman, Dara Y, Klimek, Virginia, Young, James W., O'Reilly, Richard J., Giralt, Sergio A., Castro-Malaspina, Hugo
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4764129/
https://ncbi.nlm.nih.gov/pubmed/26187863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.07.010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares